Divergence
Status: Neutral
Point system: 1 = meets criteria, 0 = fails or not applicable
Total points: 7
Horizontal S&R: 1
Channel S&R: 1
MA S&R: 1
Pearson's R >= 85: 1
Price Fib Ext >1.382: 1
Next Earnings date: 10/20
Favorable EPS: 0, beat
Favorable Rev: 0, consistently beating
estimize.com/ilmn
Short Float: 4%, 1
*stop 1 atr below swing low.
** first price target is 50% the move from entry price to previous high.
***No Biotech
**** Only short if price is below 50 and/or 200 ma
Any feedback is welcomed! Thx
Cost basis:
Stop:
First price target:
Status: Neutral
Point system: 1 = meets criteria, 0 = fails or not applicable
Total points: 7
Horizontal S&R: 1
Channel S&R: 1
MA S&R: 1
Pearson's R >= 85: 1
Price Fib Ext >1.382: 1
Next Earnings date: 10/20
Favorable EPS: 0, beat
Favorable Rev: 0, consistently beating
estimize.com/ilmn
Short Float: 4%, 1
*stop 1 atr below swing low.
** first price target is 50% the move from entry price to previous high.
***No Biotech
**** Only short if price is below 50 and/or 200 ma
Any feedback is welcomed! Thx
Cost basis:
Stop:
First price target:
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.